Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Learn more about the possibilities of this page

Avenue Therapeutics Inc. Stock

Price
Target price
€0.090

€0.090

5.760%
0.0049
5.760%
€0.70
 
14:07 / Tradegate WKN: A3DWU7 / Symbol: ATXI / Name: Avenue Therapeutics / Stock / Pharmaceuticals / Small Cap /
Please give a prediction to see the opinions of the community
Buy
None
Sell
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Pros and Cons of Avenue Therapeutics Inc. in the next few years
Wizard

Avenue Therapeutics Inc. Stock

Avenue Therapeutics Inc. dominated the market today, gaining €0.005 (5.760%).
Currently there is a rather positive sentiment for Avenue Therapeutics Inc. with 3 Buy predictions and 0 Sell predictions.
Our community identified positive and negative aspects for Avenue Therapeutics Inc. stock for the coming years. 3 users see the criterium "Company culture" as a plus for the Avenue Therapeutics Inc. stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
What does Avenue Therapeutics do?

Pros and Cons of Avenue Therapeutics Inc. in the next few years

Pros
?
B****
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Cons
?
S********** s********
?
M***** P*******
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Your Opinion
Legal notice

Performance of Avenue Therapeutics Inc. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Avenue Therapeutics Inc. 5.760% -31.452% -39.155% -90.885% -42.876% - -
Avid Bioservices Inc - -1.563% 1.613% -64.804% 3.279% -64.000% 54.753%
Rockwell Medical Inc. 1.620% -4.810% -3.193% -26.923% -20.034% -85.152% -96.854%
Gritstone Oncology Inc -5.040% 9.065% -69.921% -67.350% -58.881% -89.974% -

Comments

Prediction Buy
Perf. (%) -31.06%
Target price 0.698
Change
Ends at 11.12.24

Avenue Therapeutics, Inc. (NASDAQ: ATXI) is now covered by analysts at Maxim Group. They set a "buy" rating and a $0.75 price target on the stock.
Ratings data for ATXI provided by MarketBeat
Show more

Maxim Group 
0
Report Share
11.12.23
Prediction Buy
Perf. (%) -87.88%
Target price 29.347
Change
Ends at 03.04.24

Avenue Therapeutics, Inc. (NASDAQ: ATXI) is now covered by analysts at Aegis. They set a "buy" rating and a $32.00 price target on the stock.
Ratings data for ATXI provided by MarketBeat
Show more

Aegis 
0
Report Share
03.04.23
Show more
Not a member yet? Sign up for free!